Searched for
PHARMEASY MARKET SHARE
FirstCry, Slice’s FY26 numbers; Nilekani’s Fundamentum eyes deeptech pushFirstCry parent cut its losses in the March quarter on tightened costs. This and more in today's ETtech Top 5.- Drugs at your door: Signs of a disruption taking shape in IndiaIndia Pharmacy Retail Quick Commerce: India's medicine delivery is seeing a change. Quick-commerce apps are making it easier to buy medicin...
- PharmEasy halves loss to Rs 2,533 crore in FY24, revenue dips 15%Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2,533 crore, an improvement from the Rs 5,212 crore los...
- CCI clears Ranjan Pai’s investment in PharmEasyRanjan Pai invests in PharmEasy's funding with 360 One. API Holdings board seats acquired. Rights issue resolves debt. Monthly burn reducti...
- PharmEasy’s FY23 operating revenue up 16% to Rs 6,644 crore; net loss widens 30%PharmEasy’s parent firm API Holdings cut down its advertising and promotional expenses to Rs 235 crore, less than half of what it incurred ...
- 1mg overtakes PharmEasy in market share in top order changeTata 1mg had a 31% market share in September 2023 against 19% in October 2022 while PharmEasy slipped to 15% from about 33% during the same...
- Goldman may convert part-debt into equity in PharmEasyThe online pharmacy is also in talks to restructure debt terms ahead of rights issue; share sale set to open on September 4
- ETtech Explainer: What are down rounds and will they become the norm for Indian startups?A down round is when a privately held firm raises funds at a valuation lower than that ascribed in the previous round.
- PharmEasy valuation crash may not hit Thyrocare founder Velumani’s stakePharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per ...
- Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to boardPharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...
- PharmEasy floats rights issue to raise Rs 750 croreThe company's existing investors like Prosus Ventures and Temasek as well as its founders have subscribed to the issue for shares worth abo...
- PharmEasy prepares Rs 750 crore funding through convertible notesProsus Ventures, Temasek and others participate; online pharmacy reconsidering external fundraise amid funding slowdown
- PharmEasy plans $200 million fund raising at lower valuationPharmEasy's planned fund raising is set to see participation from some existing investors, who have indicated they will commit about $115 m...
- Sebi clears PharmEasy’s Rs 6,250 crore IPOMumbai-based API Holdings had filed its draft IPO papers in November to raise Rs 6,250 crore through a sale of primary shares. Existing sha...
- PharmEasy parent company gets Sebi nod for Rs 6,250-cr public offerAPI Holdings, the parent firm of PharmEasy, has got clearance from markets regulator Securities and Exchange Board of India for the online ...
- PharmEasy may have to rework IPO valuation as street mood swingsUnlike Delhivery and Oyo Hotels & Homes, its IPO is fully through primary share sale and doesn’t have an OFS (offer for sale) component. It...
- PharmEasy parent API Holdings files papers for Rs 6,250 crore IPOAPI Holdings, the parent of online pharmacy PharmEasy, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for a ₹...
- Exclusive: New investors in talks to join PharmEasy’s pre-IPO funding roundThe company has also finalised a secondary transaction of around $100 million in which some existing investors, such as Infosys cofounder N...
- PharmEasy to acquire 66% stake in Thyrocare for over Rs 4,500 crorePharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies, in what the online pharmacy claimed was the first ever...
- PharmEasy in investment talks with Naspers, TPGOnline pharmacies such as PharmEasy and 1mg have registered growth outside their core metropolitan markets by rapidly expanding into tier-2...
Load More
